(Q47678735)

4 February 2018

review article

1 reference

title

Prevention of type 1 diabetes. (English)

1 reference

4 February 2018

0 references

2

J S Skyler

1 reference

4 February 2018

author name string

A Rabinovitch

series ordinal

1

1 reference

4 February 2018

publication date

1 July 1998

1 reference

4 February 2018

Medical Clinics of North America

published in

1 reference

4 February 2018

volume

82

1 reference

4 February 2018

page(s)

739-755

1 reference

4 February 2018

issue

4

1 reference

4 February 2018

Cell death mediators in autoimmune diabetes--no shortage of suspects

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970022-5

Oral administration of human insulin to NOD mice generates CD4+ T cells that suppress adoptive transfer of diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970022-5

Residual Beta-cell Function and Its Metabolic Consequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970022-5

In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970022-5

Factors associated with early remission of type I diabetes in children treated with cyclosporine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970022-5

Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970022-5

Detection of cell-mediated immunity in Type I diabetes mellitus☆

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970022-5

Essential role for interferon-gamma and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970022-5

Cytokines in sera from insulin-dependent diabetic patients at diagnosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970022-5

In vitro secretion of interleukin-1 beta and interferon-gamma by peripheral blood lymphomononuclear cells in diabetic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970022-5

Does nitric oxide mediate autoimmune destruction of beta-cells? Possible therapeutic interventions in IDDM

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970022-5

Intraislet release of interleukin 1 inhibits beta cell function by inducing beta cell expression of inducible nitric oxide synthase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970022-5

Metabolic control in 131 juvenile-onset diabetic patients as measured by HbA1c: relation to age, duration, C-peptide, insulin dose, and one or two insulin injections.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970022-5

Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970022-5

Effects of age, duration and treatment of insulin-dependent diabetes mellitus on residual beta-cell function: observations during eligibility testing for the Diabetes Control and Complications Trial (DCCT). The DCCT Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970022-5

Prevention of diabetes in NOD mice treated with antibody to murine IFN gamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970022-5

Persistent insulin secretion, assessed by plasma C-peptide estimation in long-term juvenile diabetics with a low insulin requirement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970022-5

Cyclosporin increases the rate and length of remissions in insulin-dependent diabetes of recent onset. Results of a multicentre double-blind trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970022-5

Immunoreactive alpha-interferon in insulin-secreting beta cells in type 1 diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970022-5

Insulitis in type 1 (insulin-dependent) diabetes mellitus in man--macrophages, lymphocytes, and interferon-gamma containing cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970022-5

Evidence that the T cell repertoire of normal rats contains cells with the potential to cause diabetes. Characterization of the CD4+ T cell subset that inhibits this autoimmune potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970022-5

The pancreatic islets in diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970022-5

Control of juvenile diabetes mellitus and its relationship to endogenous insulin secretion as measured by C-peptide immunoreactivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970022-5

Macrophages, T cell receptor usage, and endothelial cell activation in the pancreas at the onset of insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970022-5

Aerosol insulin induces regulatory CD8 gamma delta T cells that prevent murine insulin-dependent diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970022-5

Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970022-5

In vivo activity and in vitro specificity of CD4+ Th1 and Th2 cells derived from the spleens of diabetic NOD mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970022-5

Differential regulation of T helper phenotype development by interleukins 4 and 10 in an alpha beta T-cell-receptor transgenic system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970022-5

Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970022-5

Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970022-5

T helper cell subsets in insulin-dependent diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970022-5

Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970022-5

Insulin prophylaxis in individuals at high risk of type I diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970022-5

Transcription and translation of inducible nitric oxide synthase in the pancreas of prediabetic BB rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970022-5

Autoimmune versus inflammatory type I diabetes: a controversy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970022-5

Transfer of insulin-dependent diabetes between HLA-identical siblings by bone marrow transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970022-5

Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970022-5

C-peptide in juvenile diabetics beyond the postinitial remission period. Relation to clinical manifestations at onset of diabetes, remission and diabetic control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970022-5

Transgenic plants expressing autoantigens fed to mice to induce oral immune tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970022-5

Prevalence of residual B cell function and its metabolic consequences in Type 1 (insulin-dependent) diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970022-5

The transient effect of strict glycaemic control on B cell function in newly diagnosed Type 1 (insulin-dependent) diabetic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970022-5

Sustained insulin-induced remissions of juvenile diabetes by means of an external artificial pancreas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970022-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970022-5

TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970022-5

Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon-gamma transcription

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970022-5

MHC class-II molecules and autoimmunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970022-5

Prevention of diabetes in BB/Wor rats treated with monoclonal antibodies to interferon-gamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970022-5

Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970022-5

Transfer of type 1 (insulin-dependent) diabetes mellitus associated autoimmunity to mice with severe combined immunodeficiency (SCID)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970022-5

Oral administration of the immunodominant B-chain of insulin reduces diabetes in a co-transfer model of diabetes in the NOD mouse and is associated with a switch from Th1 to Th2 cytokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970022-5

Cytokine regulation of T-cell function: potential for therapeutic intervention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970022-5

Meta-analysis of nicotinamide treatment in patients with recent-onset IDDM. The Nicotinamide Trialists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970022-5

Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970022-5

T-cell reactivity to 38 kD insulin-secretory-granule protein in patients with recent-onset type 1 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970022-5

Lymphokine production by human T cells in disease states

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970022-5

Cyclophosphamide treatment of female non-obese diabetic mice causes enhanced expression of inducible nitric oxide synthase and interferon-gamma, but not of interleukin-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970022-5

Insulin-dependent diabetes mellitus induced in transgenic mice by ectopic expression of class II MHC and interferon-gamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970022-5

IL-12: initiation cytokine for cell-mediated immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970022-5

Acquisition of lymphokine-producing phenotype by CD4+ T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970022-5

The presence of interleukin 4 during in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970022-5

A randomized trial of intensive insulin therapy in newly diagnosed insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970022-5

Immunosuppression with azathioprine and prednisone in recent-onset insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970022-5

Influence of microbial agents on the development and prevention of autoimmune diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970022-5

Particular HLA-DQ molecules play a dominant role in determining susceptibility or resistance to type 1 (insulin-dependent) diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970022-5

Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970022-5

Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970022-5

Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970022-5

Roles of multiple accessory molecules in T-cell activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970022-5

Autoimmune polyendocrine failure--type 1 (insulin-dependent) diabetes mellitus and hypothyroidism--after allogeneic bone marrow transplantation in a patient with lymphoblastic leukaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970022-5

The primary lesion theory of autoimmunity: a speculative hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970022-5

Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970022-5

Delay of type I diabetes in high risk, first degree relatives by parenteral antigen administration: the Schwabing Insulin Prophylaxis Pilot Trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970022-5

Nicotinamide treatment in the prevention of insulin-dependent diabetes mellitus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970022-5

inferred from DOI database lookup

7 January 2021

based on heuristic

The potential role of nicotinamide in the secondary prevention of IDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970022-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Prophylactic insulin treatment in relatives at high risk for type 1 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970022-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0025-7125(05)70022-5

1 reference

4 February 2018

PubMed ID

9706119

1 reference

4 February 2018